A Phase 1, First-in-Human Study of BMS-986421 in Healthy Participants
Clinical trial NCT05517837 · TERMINATED
Trial details
- NCT number
- NCT05517837
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-13
- Primary completion
- 2023-07-14
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.